While IFN-γ sensing program induces TNFRSF14 upregulation in tumor cells, this cancer intrinsic TNFRSF14 elevation augments the recruitment of anti-inflammatory TAMs in preclinical mouse GBM model. The gene discussed is TNFRSF14; the disease is glioblastoma.